Year: 2012

A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.

Sponsor:

Flexion Therapeutics

CRO:

N/A

Study ID:

FX006-2011-001

Phase:

N/A

Partnership for Advancement in Neuromodulation (PAIN): A Prospective Clinical Outcomes Registry.

Sponsor:

St Jude Medical

CRO:

N/A

Study ID:

C-09-01

Phase:

Observational

CONNECT WITH US

CONTACT US

Disclaimer: This website provides general information only; it should not be construed as medical advice nor does it replace the need to seek medical advice from a qualified medical professional. To the maximum extent permitted by law, Genesis Research Services Pty Ltd will not be liable in any way for any injury, loss or damage suffered by you through accessing or using the information on this website. View our Privacy Policy. You are strictly prohibited from downloading, copying, altering, modifying, distributing, adapting, modifying and/or re-transmitting any or all of the content on the website for any commercial use without the written consent of Genesis Research Services.